Cardinal Health, Inc.

NYSE CAH

Cardinal Health, Inc. Price to Sales Ratio (P/S) on January 14, 2025: 0.13

Cardinal Health, Inc. Price to Sales Ratio (P/S) is 0.13 on January 14, 2025, a 12.71% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Cardinal Health, Inc. 52-week high Price to Sales Ratio (P/S) is 0.14 on December 04, 2024, which is 1.91% above the current Price to Sales Ratio (P/S).
  • Cardinal Health, Inc. 52-week low Price to Sales Ratio (P/S) is 0.10 on July 15, 2024, which is -25.55% below the current Price to Sales Ratio (P/S).
  • Cardinal Health, Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 0.12.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
NYSE: CAH

Cardinal Health, Inc.

CEO Mr. Jason M. Hollar
IPO Date Aug. 4, 1983
Location United States
Headquarters 7000 Cardinal Place
Employees 47,922
Sector Health Care
Industries
Description

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Similar companies

HSIC

Henry Schein, Inc.

USD 71.27

0.81%

MCK

McKesson Corporation

USD 593.73

1.48%

EDAP

EDAP TMS S.A.

USD 2.02

-2.42%

ZYXI

Zynex, Inc.

USD 7.66

-1.42%

PDCO

Patterson Companies, Inc.

USD 30.89

0.16%

OMI

Owens & Minor, Inc.

USD 14.74

1.17%

StockViz Staff

January 15, 2025

Any question? Send us an email